The Notice on Supporting Hong Kong and Macao Drug Marketing Authorization Holders to Produce Drugs in the Nine Mainland Cities of the Greater Bay Area was issued on Jun.29, 2022. It aims to promote the reform of the system of drug marketing license holders and medical device registrants in the Guangdong-Hong Kong-Macao Greater Bay Area, which includes relevant policies, regulations, and measures.
- Local Title:支持港澳药品上市许可持有人在大湾区内地9市生产药品实施方案
- Country/Region:Chinese Mainland
- Competent Authority: National Medical Products Administration (NMPA)
- Type:Notice
- Status:In force
- Release Date:2022-06-29
- Implementation Date:2022-06-29